Morepen Laboratories Limited has informed the Exchange about change in Senior Management Personnel on account of resignation.
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 3.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Morepen Laboratories informed the exchanges that Mr. Naresh Sharma, Vice President – Operations (API) and Factory Manager, has resigned due to personal reasons, effective May 5, 2025. The disclosure was made under Regulation 30 of the SEBI Listing Regulations, along with the resignation email as supporting evidence. Mr. Sharma's email cited unavoidable personal circumstances as the reason for stepping down. No replacement or interim arrangement has been mentioned in this filing.
This is a mid-to-senior operational-level exit rather than a top leadership change, so the direct impact on stock price or shareholder value is likely limited. Investors may watch for any disruption in API operations or a timely successor appointment, but the resignation itself is routine in nature.